List of Tables
Table 1. Global Antimicrobial Peptides Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Antimicrobial Peptides Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Antimicrobial Peptides Market Competitive Situation by Manufacturers in 2023
Table 4. Global Antimicrobial Peptides Sales (Mg) of Key Manufacturers (2019-2024)
Table 5. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Antimicrobial Peptides Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Antimicrobial Peptides Average Price (US$/Mg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Antimicrobial Peptides, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
Table 12. Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Antimicrobial Peptides Sales by Region (2019-2024) & (Mg)
Table 18. Global Antimicrobial Peptides Sales Market Share by Region (2019-2024)
Table 19. Global Antimicrobial Peptides Sales by Region (2025-2030) & (Mg)
Table 20. Global Antimicrobial Peptides Sales Market Share by Region (2025-2030)
Table 21. Global Antimicrobial Peptides Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Antimicrobial Peptides Revenue Market Share by Region (2019-2024)
Table 23. Global Antimicrobial Peptides Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Antimicrobial Peptides Revenue Market Share by Region (2025-2030)
Table 25. North America Antimicrobial Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
Table 27. North America Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
Table 28. North America Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Antimicrobial Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
Table 32. Europe Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
Table 33. Europe Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Antimicrobial Peptides Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Antimicrobial Peptides Sales by Region (2019-2024) & (Mg)
Table 37. Asia Pacific Antimicrobial Peptides Sales by Region (2025-2030) & (Mg)
Table 38. Asia Pacific Antimicrobial Peptides Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Antimicrobial Peptides Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antimicrobial Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
Table 42. Latin America Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
Table 43. Latin America Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Antimicrobial Peptides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
Table 47. Middle East & Africa Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
Table 48. Middle East & Africa Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Antimicrobial Peptides Sales (Mg) by Type (2019-2024)
Table 51. Global Antimicrobial Peptides Sales (Mg) by Type (2025-2030)
Table 52. Global Antimicrobial Peptides Sales Market Share by Type (2019-2024)
Table 53. Global Antimicrobial Peptides Sales Market Share by Type (2025-2030)
Table 54. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Antimicrobial Peptides Revenue Market Share by Type (2019-2024)
Table 57. Global Antimicrobial Peptides Revenue Market Share by Type (2025-2030)
Table 58. Global Antimicrobial Peptides Price (US$/Mg) by Type (2019-2024)
Table 59. Global Antimicrobial Peptides Price (US$/Mg) by Type (2025-2030)
Table 60. Global Antimicrobial Peptides Sales (Mg) by Application (2019-2024)
Table 61. Global Antimicrobial Peptides Sales (Mg) by Application (2025-2030)
Table 62. Global Antimicrobial Peptides Sales Market Share by Application (2019-2024)
Table 63. Global Antimicrobial Peptides Sales Market Share by Application (2025-2030)
Table 64. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Antimicrobial Peptides Revenue Market Share by Application (2019-2024)
Table 67. Global Antimicrobial Peptides Revenue Market Share by Application (2025-2030)
Table 68. Global Antimicrobial Peptides Price (US$/Mg) by Application (2019-2024)
Table 69. Global Antimicrobial Peptides Price (US$/Mg) by Application (2025-2030)
Table 70. AnaSpec Corporation Information
Table 71. AnaSpec Description and Business Overview
Table 72. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 73. AnaSpec Antimicrobial Peptides Product
Table 74. AnaSpec Recent Developments/Updates
Table 75. AMP Biotech Corporation Information
Table 76. AMP Biotech Description and Business Overview
Table 77. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 78. AMP Biotech Antimicrobial Peptides Product
Table 79. AMP Biotech Recent Developments/Updates
Table 80. Phoenix Biotech Corporation Information
Table 81. Phoenix Biotech Description and Business Overview
Table 82. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 83. Phoenix Biotech Antimicrobial Peptides Product
Table 84. Phoenix Biotech Recent Developments/Updates
Table 85. Novabiotics Corporation Information
Table 86. Novabiotics Description and Business Overview
Table 87. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 88. Novabiotics Antimicrobial Peptides Product
Table 89. Novabiotics Recent Developments/Updates
Table 90. Chinese Peptide Corporation Information
Table 91. Chinese Peptide Description and Business Overview
Table 92. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 93. Chinese Peptide Antimicrobial Peptides Product
Table 94. Chinese Peptide Recent Developments/Updates
Table 95. Ontores Corporation Information
Table 96. Ontores Description and Business Overview
Table 97. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 98. Ontores Antimicrobial Peptides Product
Table 99. Ontores Recent Developments/Updates
Table 100. GenScript Corporation Information
Table 101. GenScript Description and Business Overview
Table 102. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 103. GenScript Antimicrobial Peptides Product
Table 104. GenScript Recent Developments/Updates
Table 105. Hycult Biotech Corporation Information
Table 106. Hycult Biotech Description and Business Overview
Table 107. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 108. Hycult Biotech Antimicrobial Peptides Product
Table 109. Hycult Biotech Recent Developments/Updates
Table 110. Sunsmile Corporation Information
Table 111. Sunsmile Description and Business Overview
Table 112. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 113. Sunsmile Antimicrobial Peptides Product
Table 114. Sunsmile Recent Developments/Updates
Table 115. Ruixing Biotechnology Corporation Information
Table 116. Ruixing Biotechnology Description and Business Overview
Table 117. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 118. Ruixing Biotechnology Antimicrobial Peptides Product
Table 119. Ruixing Biotechnology Recent Developments/Updates
Table 120. Zhongnong Yingtai Biotechnology Corporation Information
Table 121. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 122. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 123. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 124. Zhongnong Yingtai Biotechnology Recent Developments/Updates
Table 125. Glam Technology Corporation Information
Table 126. Glam Technology Description and Business Overview
Table 127. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 128. Glam Technology Antimicrobial Peptides Product
Table 129. Glam Technology Recent Developments/Updates
Table 130. ProteLight Pharmaceutical & Biotechnology Corporation Information
Table 131. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 132. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 133. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 134. ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Trends
Table 140. Antimicrobial Peptides Market Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Antimicrobial Peptides Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antimicrobial Peptides
Figure 2. Global Antimicrobial Peptides Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antimicrobial Peptides Market Share by Type in 2023 & 2030
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Antimicrobial Peptides Market Share by Application in 2023 & 2030
Figure 9. Pharmaceuticals
Figure 10. Feed Additives
Figure 11. Others
Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Antimicrobial Peptides Market Size (2019-2030) & (US$ Million)
Figure 14. Global Antimicrobial Peptides Sales (2019-2030) & (Mg)
Figure 15. Global Antimicrobial Peptides Average Price (US$/Mg) & (2019-2030)
Figure 16. Antimicrobial Peptides Report Years Considered
Figure 17. Antimicrobial Peptides Sales Share by Manufacturers in 2023
Figure 18. Global Antimicrobial Peptides Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Antimicrobial Peptides Players: Market Share by Revenue in 2023
Figure 20. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Antimicrobial Peptides Sales Market Share by Country (2019-2030)
Figure 23. North America Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Antimicrobial Peptides Sales Market Share by Country (2019-2030)
Figure 27. Europe Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
Figure 28. Germany Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Antimicrobial Peptides Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Antimicrobial Peptides Revenue Market Share by Region (2019-2030)
Figure 35. China Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Antimicrobial Peptides Sales Market Share by Country (2019-2030)
Figure 46. Latin America Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Antimicrobial Peptides Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Antimicrobial Peptides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Antimicrobial Peptides by Type (2019-2030)
Figure 56. Global Revenue Market Share of Antimicrobial Peptides by Type (2019-2030)
Figure 57. Global Antimicrobial Peptides Price (US$/Mg) by Type (2019-2030)
Figure 58. Global Sales Market Share of Antimicrobial Peptides by Application (2019-2030)
Figure 59. Global Revenue Market Share of Antimicrobial Peptides by Application (2019-2030)
Figure 60. Global Antimicrobial Peptides Price (US$/Mg) by Application (2019-2030)
Figure 61. Antimicrobial Peptides Value Chain
Figure 62. Antimicrobial Peptides Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
